ClinicalTrials.Veeva

Menu

The Effect of Electronic Cigarette Liquid Characteristics in Smokers.

Virginia Commonwealth University (VCU) logo

Virginia Commonwealth University (VCU)

Status

Completed

Conditions

Electronic Cigarettes

Treatments

Other: ECIG 15 mg nicotine, unsweet
Other: Own Brand Cigarette
Other: ECIG 0 mg nicotine, sweetened
Other: ECIG 15 mg nicotine, sweetened
Other: ECIG 0 mg nicotine, unsweet

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03861078
HM20015258
F31DA047018 (U.S. NIH Grant/Contract)
U54DA036105 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to determine differences in nicotine delivery, user behaviors, subjective effects, and physiological effects, when cigarette smokers use an electronic cigarette with different nicotine (and sweetener) concentrations relative to using their own brand of cigarettes.

Enrollment

22 patients

Sex

All

Ages

21 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria-- Participants must be:

  • Healthy (determined by self-report)
  • Between the ages of 21-55 years old
  • Current cigarette smokers
  • Wiling to provide informed consent
  • Able to attend the lab session and abstain from tobacco/nicotine products as required
  • Agree to use designated products according to the study protocol

Exclusion Criteria:

  • Women if they are breast-feeding or test positive for pregnancy (by urinalysis) at screening.
  • Individuals who weigh less than 110 pounds.

Some study details about the eligibility criteria are purposely omitted at this time to preserve scientific integrity. Full details will be posted at the conclusion of the study.

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Crossover Assignment

Masking

None (Open label)

22 participants in 1 patient group

Cigarette smokers
Experimental group
Description:
Each participant will participate in 5 sessions. During each session, participants will complete a 10-puff, directed product use bout, and then have the option later to puff as little or as much as they like during a 30-minute self administration task. Session 1: Own brand cigarette use Session 2: ECIG 15 mg nicotine, sweetened Session 3: ECIG Lab Session ECIG 15 mg nicotine, unsweetened Session 4: ECIG Lab Session ECIG 0 mg nicotine, sweetened Session 5: ECIG Lab Session ECIG 0 mg nicotine, unsweetened
Treatment:
Other: ECIG 0 mg nicotine, sweetened
Other: Own Brand Cigarette
Other: ECIG 15 mg nicotine, unsweet
Other: ECIG 0 mg nicotine, unsweet
Other: ECIG 15 mg nicotine, sweetened

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems